FMOD and neoplasm: Moreover, analysis of clinical data from The Cancer Genome Atlas (TCGA) database indicated that FMOD is significantly upregulated in tumor samples including breast invasive ductal cancer and breast invasive lobular cancer (Figure 9D).Univariate analysis with Kaplan-Meier estimates revealed the specimens with FMOD positive staining were more likely to have an unfavorable survival when compared with the FMOD low group (p = 0.0106, Figure 9E).